World Hemophilia Day 2026: Protecting Asia’s ‘Glass People’
On World Hemophilia Day 2026, Asia focuses on early diagnosis and innovative treatments to improve care for hemophilia patients, known as ‘glass people’.
News & Insights Across Asia
On World Hemophilia Day 2026, Asia focuses on early diagnosis and innovative treatments to improve care for hemophilia patients, known as ‘glass people’.
Global healthcare giants are accelerating investments in Hainan, drawn by streamlined customs policies and untapped market potential at the 2026 Hainan Expo.
China pioneers live-streamed semi-invasive BCI surgery using domestically developed ‘Beinao No.1’ system, advancing neurorehabilitation technology.
Chinese researchers announce breakthrough cannabis-based pain treatment without addiction risks, potentially transforming global chronic care management.
Hainan’s Boao Lecheng Pilot Zone now approves global medical products in 1.6 days, offering hope for rare disease patients and attracting 180+ international partners.
China pioneers Parkinson’s treatment breakthroughs in 2026 through early detection tech, stem cell therapies, and holistic care models transforming patient outcomes.
Chinese scientists reveal groundbreaking insights into how the brain switches between memory and perception, with implications for AI and mental health treatments.
Advances in early detection and treatment are transforming gastric cancer into a manageable condition, says leading Chinese oncologist Ji Jiafu.
Dr. Jacky Tsui’s career move highlights the Greater Bay Area’s growing role as a medical innovation hub, offering opportunities for professionals and improved healthcare access.
China approves the world’s first invasive BCI medical device, enabling hand movement control for tetraplegia patients. A breakthrough in neurotechnology commercialization.
China unveils its first AI-driven ‘super hospital’ in Hainan, integrating advanced AI systems to transform healthcare delivery and global medical collaboration.
China accelerates its Healthy China 2035 vision through AI diagnostics, smart wearables, and telemedicine, transforming healthcare access and quality nationwide.
China and the US deepen medical collaboration in cancer research, neuroscience, and digital healthcare, accelerating global health advancements through shared expertise and policy innovation.
China’s medical regulator approves groundbreaking invasive brain-computer interface device, revolutionizing treatment for paralysis and neurological disorders.
China’s NMPA approves the world’s first invasive BCI device for spinal injury patients, marking a milestone in medical technology and future industry growth.
China’s tertiary hospitals implement multidisciplinary weight management systems under the Healthy China 2030 Initiative, targeting chronic disease prevention through medical interventions.
Leading thoracic surgeon Zhou Qinghua discusses balancing cutting-edge lung cancer treatments with patient-centered care in China’s evolving healthcare landscape.
DeepRare AI achieves 70% diagnostic accuracy for rare diseases, cutting diagnosis times and reducing misdiagnoses, per new Nature study.
Chinese researchers unveil stretchable electrodes enhancing brain-computer interface stability, published in Nature Electronics. A leap for neurotech and medical applications.
KAIST researchers discover molecular mechanism to reverse cancer cell progression, potentially revolutionizing oncology treatment approaches in 2026.